Reboot Rx Inc

Because the solution may already exist.

Winchester, MA   |  https://rebootrx.org

Mission

Reboot Rx is the nonprofit health tech startup dedicated to fast-tracking the development of affordable cancer treatments using repurposed generic drugs, AI technology, and innovative funding models.

Ruling year info

2020

Founder and CEO

Laura Kleiman PhD

Main address

45 Thornberry Road

Winchester, MA 01890 USA

Show more contact info

EIN

84-4384737

NTEE code info

Education N.E.C. (B99)

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Sign in or create an account to view Form(s) 990 for 2020.
Register now

Communication

Blog

Programs and results

What we aim to solve

SOURCE: Self-reported by organization

Reboot Rx is solving a big problem. Each year worldwide there are 17 million new cancer diagnoses, 10 million people die from cancer, and $1 trillion is spent on cancer care. What if we could save lives with existing low-cost drugs?

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

AI Technology for Drug Repurposing

We are developing evidence synthesis technology powered by AI and machine learning to quickly sift through large amounts of data and find the most promising generic drugs to repurpose for cancer.

Population(s) Served
Health

Where we work

Our Sustainable Development Goals

SOURCE: Self-reported by organization

Learn more about Sustainable Development Goals.

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

Reboot Rx is the tech nonprofit startup dedicated to fast-tracking the development of affordable cancer treatments to save the lives of cancer patients worldwide.

Our strategy leverages repurposed generic non-cancer drugs for the treatment of cancer. We are building AI technology to sift through large amounts of existing data to prioritize candidate drugs. We are also developing innovative funding models and convening stakeholders to advance the top drug candidates to the standard of care for cancer patients.

The Reboot Rx team has experts in cancer drug development, medical oncology, AI and machine learning, business and nonprofit management, policy, and patient advocacy.

In 2020, Reboot Rx launched the Reboot: COVID-Cancer Project, a proof of concept of our technology with immediate patient impact. We used our technology to quickly sift through 2M + published studies and registered trials and found the 37K + studies most relevant for COVID-19 and cancer patients. We extracted key information from these studies and made the aggregated data freely available in interactive dashboards. Now we’re conducting the largest meta-analyses on COVID-19 and cancer to date in order to uncover whether certain cancer patient populations are particularly vulnerable to COVID-19 and which treatments may be most effective.

Reboot Rx has deployed its technology to synthesize the cancer data for all non-cancer generic drugs and generated an initial ranked list of the most promising generics to repurpose for the treatment of cancer.

Financials

Reboot Rx Inc
lock

Unlock financial insights by subscribing to our monthly plan.

Subscribe

Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more about GuideStar Pro.

Operations

The people, governance practices, and partners that make the organization tick.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

Reboot Rx Inc

Board of directors
as of 1/25/2022
SOURCE: Self-reported by organization
Board chair

Andrea Pollinger

David Noymer

Mason Irving III

Laura Kleiman

Board leadership practices

SOURCE: Self-reported by organization

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.

  • CEO oversight
    Has the board conducted a formal, written assessment of the chief executive within the past year ? Yes

Organizational demographics

SOURCE: Self-reported; last updated 01/24/2022

Who works and leads organizations that serve our diverse communities? GuideStar partnered on this section with CHANGE Philanthropy and Equity in the Center.

Leadership

The organization's leader identifies as:

Race & ethnicity
White/Caucasian/European
Gender identity
Female
Sexual orientation
Decline to state
Disability status
Decline to state

Race & ethnicity

Gender identity

 

Sexual orientation

No data

Disability

No data